Abstract
Twenty patients with APL in long-term remission after BMT were analyzed for the presence of the PML-RARα x fusion gene by RT-PCR. Ten patients had undergone autologous BMT (six of them peripheral blood stem cell transplantation) and 10 allogeneic BMT. A total of 60 samples were examined by two different protocols. Of the eight patients studied just before conditioning, five showed PML-RARα transcript prior to transplantation. Three of them were in CR and became PCR negative early post-transplantation. The other two patients, that were not in CR before transplant, remained PCR positive, relapsed early post-transplant and died. In the remaining patients no PML-RARα transcripts were visible throughout their post-BMT courses. Our data show that long-term remission after BMT in APL patients is associated with eradication of cells carrying the PML-RAR α transcript, and that continued positivity of this test predicts subsequent relapse. The fact of the disappearance of PML-RARα transcript early after BMT in patients previously positive suggest that transplant is capable of curing APL mainly through antileukemic action of the conditioning regimen and therefore, transplantation must be indicated in CR patients if a positive RT-PCR remains after treatment with ATRA plus chemotherapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Román, J., Martín, C., Torres, A. et al. Absence of detectable PML-RARα fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Bone Marrow Transplant 19, 679–683 (1997). https://doi.org/10.1038/sj.bmt.1700712
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700712
Keywords
This article is cited by
-
Molecular Monitoring as a Path to Cure Acute Promyelocytic Leukemia
Rare Cancers and Therapy (2015)
-
Role of autotransplantation in the treatment of acute promyelocytic leukemia patients in remission: Fukuoka BMT Group observations and a literature review
Bone Marrow Transplantation (2011)
-
Auto-SCT for AML in second remission: CALGB Study 9620
Bone Marrow Transplantation (2009)
-
Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation
Bone Marrow Transplantation (2007)
-
Autologous stem cell transplantation for acute myeloid leukemia
Bone Marrow Transplantation (2003)